Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Genital Wart
  • AIS
  • Cervical Cancer
  • CIN1
  • CIN2
  • VIN 2
  • VIN 3
  • CIN3
  • Vaginal Cancer
  • VaIN1
  • VaIN2
  • Vulvar Cancer
  • VaIN3
  • VIN 1
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Prevention

Participation Requirements

Age
Between 20 years and 45 years
Gender
Only males

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04425291
Collaborators
Chongqing Bovax Biopharmaceutical Co., Ltd.
Investigators
Not Provided